Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2012 Dec;13(12):1179-80.
doi: 10.1016/S1470-2045(12)70501-6. Epub 2012 Nov 7.

Taking the starch out of hereditary colorectal cancer

Affiliations
Comment

Taking the starch out of hereditary colorectal cancer

C Richard Boland. Lancet Oncol. 2012 Dec.
No abstract available

PubMed Disclaimer

Conflict of interest statement

I declare that I have no conflicts of interest.

Comment on

References

    1. Mathers JC, Movahedi M, Macrae F, et al. on behalf of the CAPP2 Investigators. Long-term effect of resistant starch on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial. Lancet Oncol. 2012 published online Nov 7. http://dx.doi.org/10.1016/S1470-2045(12)70475-8. - DOI - PubMed
    1. Boland CR. Evolution of the nomenclature for the hereditary colorectal cancer syndromes. Fam Cancer. 2005;4:211–18. - PubMed
    1. Burn J, Bishop DT, Mecklin JP, et al. Effect of aspirin or resistant starch on colorectal neoplasia in the Lynch syndrome. N Engl J Med. 2008;359:2567–78. - PubMed
    1. Burn J, Gerdes AM, Macrae F, et al. on behalf of the CAPP2 Investigators. Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial. Lancet. 2011;378:2081–87. - PMC - PubMed
    1. Cuzick J, Otto F, Baron JA, et al. Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement. Lancet Oncol. 2009;10:501–07. - PubMed

MeSH terms